Publication | Open Access

The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice

Bile Acid HomeostasisHepatologyAllergyEthanol-induced Liver DiseaseMedicineLiver PhysiologyGastroenterologyGut Barrier FunctionHepatotoxicityLiver DiseaseAlcohol-related Liver DiseaseFatty Liver DiseasePharmacologyDrug-induced Liver Injury